SI1028718T1 - Extended release formulation containing venlafaxin - Google Patents

Extended release formulation containing venlafaxin

Info

Publication number
SI1028718T1
SI1028718T1 SI9830421T SI9830421T SI1028718T1 SI 1028718 T1 SI1028718 T1 SI 1028718T1 SI 9830421 T SI9830421 T SI 9830421T SI 9830421 T SI9830421 T SI 9830421T SI 1028718 T1 SI1028718 T1 SI 1028718T1
Authority
SI
Slovenia
Prior art keywords
venlafaxin
release formulation
extended release
formulation containing
extended
Prior art date
Application number
SI9830421T
Other languages
Slovenian (sl)
Inventor
Deborah Marie Sherman
John Clifton Clark
John Ulrick Lamer
Stephen Andrew White
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth filed Critical Wyeth
Priority claimed from PCT/US1998/023338 external-priority patent/WO1999022724A2/en
Publication of SI1028718T1 publication Critical patent/SI1028718T1/en

Links

SI9830421T 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin SI1028718T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96432897A 1997-11-05 1997-11-05
PCT/US1998/023338 WO1999022724A2 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin
EP98956487A EP1028718B1 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Publications (1)

Publication Number Publication Date
SI1028718T1 true SI1028718T1 (en) 2003-08-31

Family

ID=27806614

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830421T SI1028718T1 (en) 1997-11-05 1998-11-03 Extended release formulation containing venlafaxin

Country Status (1)

Country Link
SI (1) SI1028718T1 (en)

Similar Documents

Publication Publication Date Title
HUP9700589A2 (en) Extended release formulation containing venlaflaxine hydrochloride
IL143496A0 (en) Controlled release formulation comprising gnrh-ii
HK1029056A1 (en) Extended release formulation containing venlafaxin
IL135295A0 (en) 2-methyl-thieno-benzodiazepine formulation
ZA9510687B (en) Sustained release caffeine formulation
SG71879A1 (en) Controlled release compositions
ZA9811461B (en) New formulation
SG71789A1 (en) Controlled release compositions
GB2310860B (en) Stable release agents
HK1026429A1 (en) New formulation
IL132989A0 (en) Carotenoid formulation
GB9724544D0 (en) Novel Formulation
EP1008352A4 (en) Brain-protective agent
ZA9810710B (en) Sustained release formulations comprising alpha-glucosidase-inhibitors
GB2322867B (en) Release agent
GB9725061D0 (en) Revitalisation formulation
GB9706957D0 (en) Formulation
SI1028718T1 (en) Extended release formulation containing venlafaxin
HU0400312D0 (en) Extended release formulation containing venlaflaxine hydrochloride
GB9711946D0 (en) Release devices
SI0797991T1 (en) Extended release formulation containing venlafaxine
GB2342044B (en) Quick release compositions
GB9404544D0 (en) Controlled release formulation
GB9725275D0 (en) Formulation
GB9721807D0 (en) Formulation